Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

NURS 6521 Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

Walden University Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder-Step-By-Step Guide

This guide will demonstrate how to complete the Walden University Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

Whether one passes or fails an academic assignment such as the Walden University Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

The introduction for the Walden University Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

After the introduction, move into the main part of the Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.

Discussion Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

The importance of mental health pharmacology therapy continues to increase. The purpose of this discussion is to share pharmacodynamics, pharmacokinetics, and treatment options of generalized anxiety disorder (GAD). In depth drug therapy comprehension of GAD improves the quality of mental health pharmacology, parallel to importance.

Pharmacodynamics

Pharmacodynamics of SSRIs, as a anxiolytic drug therapy is the focused comprehension for pharmacodynamics. Selective serotonin reuptake inhibitors (SSRIs) is the focus due to its primary mechanism of action to inhibit presynaptic reuptake of serotonin at the serotonin transporter (Edinoff, Akuly, Hanna, Ochoa, Patti, Ghaffar, … & Kaye, 2021). As a nurse practitioner understands the mode of action for SSRIs, safety and efficacy of the drug therapy improves. Factors that may affect SSRIs mechanism include genetics (Pogliani, Falvella, Cattaneo, Pileri, Moscatiello, Cheli, … & Zuccotti, 2017). Therefore practitioners would consider genetics in their patients assessment and examinations.

Pharmacokinetics

Pharmacokinetics of anxiolytic drugs are extremely important to know and appropriately take into consideration for a patient’s pharmacotherapy. Selective serotonin reuptake inhibitors (SSRIs) have favorable pharmacokinetics compared to drugs, such as, benzodiazepines (Crocco, Jaramillo, Cruz-Ortiz, & Camfield, 2017). Therefore, I chose to explore pharmacokinetics of SSRIs. SSRIs metabolic enzyme, cytochromes create large volumes of distribution (Pogliani, Falvella, Cattaneo, Pileri, Moscatiello, Cheli, … & Zuccotti, 2017). The practitioners comprehend that the creation of large volume allows SSRIs to cover more areas, which increases the safety of the drug. Other factors to consider with SSRIs pharmacokinetics is age, liver function, kidney function (Strawn, Geracioti, Rajdev, Clemenza, & Levine, 2018). If the practitioner understands that SSRIs metabolize in liver and their patient has liver failure, the drug would unsafe.

Treatment Options

Exploring treatment options for GAD is vital to patients’ mental healthcare quality. Concurrent psychotherapy and pharmacotherapy

Discussion Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

is a recommendation with first line drug therapy of selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy due to its broad-spectrum efficacy and second-line pharmacotherapies may include buspirone, benzodiazepins, SGAs and pregabalin (Strawn, Geracioti, Rajdev, Clemenza, & Levine, 2018). A patient with GAD should seek mental health therapy simultaneous as they start drug therapy; the combination of both therapies has a better chance of improving symptoms. Other treatment options are available if the first line therapy is ineffective.

Summary

Data about pharmacotherapy for mental health continues to trend with much importance. Discussions about the pharmacodynamics, pharmacokinetics, and treatment options allows nurse practitioner students to increase their knowledge on anxiolytic pharmacotherapy. As the student nurses continues to enhance their knowledge base, mental health pharmacotherapy advances.

Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: Discussion: Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

References

Crocco, E. A., Jaramillo, S., Cruz-Ortiz, C., & Camfield, K. (2017). Pharmacological management of anxiety disorders in the elderly. Current treatment options in psychiatry, 4(1), 33-46.

Edinoff, A. N., Akuly, H. A., Hanna, T. A., Ochoa, C. O., Patti, S. J., Ghaffar, Y. A., … & Kaye, A. M. (2021). Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurology International, 13(3), 387-401.

Pogliani, L., Falvella, F. S., Cattaneo, D., Pileri, P., Moscatiello, A. F., Cheli, S., … & Zuccotti, G. (2017). Pharmacokinetics and pharmacogenetics of selective serotonin reuptake inhibitors during pregnancy: an observational study. Therapeutic Drug Monitoring, 39(2), 197-201.

Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018). Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert opinion on pharmacotherapy, 19(10), 1057-1070.

Collapse

This week, I will be discussing pharmacotherapeutics for generalized anxiety disorder (GAD) reflecting on a case study for “CJ” a white single 46-year-old male who presents with a history of intermittent chest tightness, shortness of breath (SOB), and feelings of impending doom along with feelings of needing to escape/run. CJ also has a history of hypertension which is currently controlled by a low sodium diet and is overweight by 15 pounds. CJ shares that he is a local welder and relays that he has been experiencing an increased amount of stress recently due to the harshness of management at his place of employment along with the pressure of caring for his elderly parents in his home. He admits to consuming three to four beers on a nightly basis. He reports that he had a tonsillectomy when he was eight years old, but other than that his medical history is relatively unremarkable. CJ then expresses that he feels “bleh” and states that he is also somewhat nervous. He denies ever taking any psychotropic medication(s). He is currently orientated to person, place, time, and event. CJ’s speech, judgment, and dress are appropriate. He denies hallucinations (visual and/or auditory) paranoia, and/or suicidal/homicidal ideation. His affect is broad and blunted but does brighten at times during the clinical assessment. Patient was previously assessed in the emergency department and an EKG was administered. A myocardial infarction (MI) was then ruled out due to normal findings.

CJ was administered the Hamilton Anxiety Rating Scale (HAM-A) which measures the severity of symptoms related to anxiety. This scale involves 14 items relating to symptoms both psychic (degree of emotionally agitated/distressed) and somatic (physical concerns/symptoms attributed to anxiety). A zero would indicate that a symptom is not present and a score of four would indicate that the symptom is severe. Although there can be some variations for the cut-off scores, the score range is typically zero to 56 with zero to 17 indicating overall mild anxiety, 18-24 mild to moderate anxiety, 25-30 moderate to severe anxiety, and 31-56 very severe anxiety (Hallit et al., 2020).

CJ scored a 26 on the HAM-A which indicates that he is experiencing moderate to severe anxiety symptoms and treatment is advisable. The first choices of treatment were Zoloft (sertraline) 50 mg by mouth daily, imipramine 25 mg by mouth twice daily, and buspirone 10 mg by mouth twice daily. Zoloft (sertraline) is often used as a first line medication as it is a serotonin reuptake inhibitor (SSRI) and has fewer drug and food interactions than other medications, is usually well-tolerated with fewer side effects, and is most often taken only once a day. However, alcohol can increase serotonin levels and cause increased sedation along with am increased risk for serotonin syndrome. Therefore, alcohol consumption should strongly be discouraged in conjunction with any SSRI. Although safe to use in patients with hypertension, sertraline can cause weight gain. It is important that the patient’s blood pressure and weight be monitored, and a healthy diet and exercise routine encouraged. As CJ is a welder, it would also be important to caution of possible drowsiness and dizziness. Counseling may also be helpful in conjunction with pharmacological treatment to assist in establishing and growing healthy coping skills (Strawn et al., 2018).

Imipramine (tricyclic antidepressant) is not generally a first line medication for GAD as this medication is mainly prescribed for depression and would not be as effective as sertraline. Buspirone (anxiolytic) is often used short-term or as an augmentation and is not as broad spectrum as sertraline. As CJ has moments of feeling what he describes as “bleh”, sertraline often boosts moods and can improve mood and interest. Sertraline has also been proven more effective than buspirone in treating panic disorder. Lexapro (escitalopram) is also an SSRI but also has not been approved to treat panic disorder and may not be as effective as sertraline in this regard (Garakani et al., 2020).

I chose to prescribe 50 mg of Zoloft (sertraline) and then reassess four weeks as it takes a bit of time to suppress the genes that code for serotonin transporters. This suppression allows the serotonin to hang around longer and provides a calming effect (Chu A, 2020). It is important to continue to monitor the patient for symptoms and adjust dose accordingly. As CJ’s HAM-A score dropped to 18 (partial response), I chose to increase the sertraline to 75 mg by mouth daily. After four weeks the HAM-A score was 10 with a 61% reduction in symptoms, no augmentation medication/agent recommended at this time.

References

Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Losifescu, D. V. (2020). Pharmacotherapy of anxiety disorders: Current and emerging treatment options. Frontiers in Psychiatry, 11, n .p. Retrieved from https://www.frontiersin.org/articles/10.3389/fpsyt.2020.595584/full

Hallit, S., Haddad, C., Hallit, R., Kheir, N., Elias-Hallit, C. A., & Salameh, P. (2020). Validation of the hamilton anxiety rating scale and state trait anxiety inventory a and b in arabic among the labanese population. Clinic Epidemiology and Global Health, 8(4), 1104-1109. Retrieved from https://cegh.net/article/S2213-3984(20)30095-6/fulltext

Strawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018). Pharmacotherapy for generalized anxiety disorder in adults and pediatric patients: An evidence-based treatment review. Expert Opinion Pharmacotherapy, 19(10), 1057-1070. doi: 10.1080/14656566.2018.1491966

Chu A, W. R. (2020). Selective serotonin reuptake inhibitors. In StatPearls, StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK554406/

Comparing and Contrasting Pharmacologic Options for the Treatment of Generalized Anxiety Disorder

Psychological disorders, such as depression, bipolar, and anxiety disorders can present several complications for patients of all ages. These disorders affect patients physically and emotionally, potentially impacting judgment, school and/or job performance, and relationships with family and friends. Since these disorders have many drastic effects on patients’ lives, it is important for advanced practice nurses to effectively manage patient care. With patient factors and medical history in mind, it is the advanced practice nurse’s responsibility to ensure the safe and effective diagnosis, treatment, and education of patients with psychological disorders.

Generalized Anxiety Disorder is a psychological condition that affects 6.1 million Americans, or 3.1% of the US Population. Despite several treatment options, only 43.2% of those suffering from GAD receive treatment. This week you will review several different classes of medication used in the treatment of Generalized Anxiety Disorder. You will examine potential impacts of pharmacotherapeutics used in the treatment of GAD. Please focus your assignment on FDA approved indications when referring to different medication classes used in the treatment of GAD.

Resources

Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.

WEEKLY RESOURCES

To Prepare:

Review the Resources for this module and consider the principles of pharmacokinetics and pharmacodynamics.
Reflect on your experiences, observations, and/or clinical practices from the last 5 years and think about how pharmacokinetic and pharmacodynamic factors altered his or her anticipated response to a drug.
Consider factors that might have influenced the patient’s pharmacokinetic and pharmacodynamic processes, such as genetics (including pharmacogenetics), gender, ethnicity, age, behavior, and/or possible pathophysiological changes due to disease.
Think about a personalized plan of care based on these influencing factors and patient history with GAD.

By Day 3 of Week 8

Post a discussion of pharmacokinetics and pharmacodynamics related to anxiolytic medications used to treat GAD. In your discussion, utilizing the discussion highlights, compare and contrast different treatment options that can be used.

By Day 6 of Week 8

Read a selection of your colleagues’ responses and respond to at least two of your colleagues on two different days by suggesting additional factors that might have interfered with the pharmacokinetic and pharmacodynamic processes of the patients diagnosed with GAD. In addition, suggest different treatment options you would suggest to treat a patient with the topic of discussion.

Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the Reply button to complete your initial post. Remember, once you click on Post Reply, you cannot delete or edit your own posts and you cannot post anonymously. Please check your post carefully before clicking on Post Reply!